Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Pressmeddelande

Neola Medical secures U.S. trademark of Neola® logo ahead of market launch

Neola Medical

Neola Medical AB announces that the company’s Neola® logotype featuring a lung symbol has been registered as trademark in the U.S. Trademark protection is a cornerstone of Neola Medical’s commercialization strategy, reinforcing the company’s position in the neonatal market and further enhancing its competitiveness ahead of market launch in the U.S. of the company’s medical device for continuous lung monitoring of preterm born babies.

“Securing trademark registration of the Neola® logotype in the U.S. is a key component of our market launch strategy. This trademark not only safeguards our intellectual property in our most important market, but also elevates the Neola® brand as a symbol of trust and innovation in neonatal care. Our brand represents quality, safety, and an aim to transform the standard of care in neonatal intensive care units around the world.”, says CEO Hanna Sjöström

Neola Medical introduced its new company name and branding platform in 2022, to align with the company’s positioning as a leading MedTech provider in neonatal intensive care. The Neola® logo, featuring a symbol that combines the image of lungs with the letter "N," was designed to reflect this focus. Trademark registration for the Neola® logo has already been secured in Europe and China.

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical secures U.S. trademark of Neola® logo ahead of market launch

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet